NASDAQ NMS - GLOBAL MARKET · ENVB
+0.00% · +$0.0000 · Vol Not reported
Market closed · last close shown
Enveric Biosciences Inc

Enveric Biosciences Inc

Pharmaceuticals
$1.43
Card
Relationship Map

Veridion Score

BETAMEDIUM CONF · 5/6 factorsMethodology
Sentiment absence reason unknown
ENVB
Enveric Biosciences Inc
Fri Aug 21 · last completed session · Pre-market · regular session opens 9:30 ET
BUY BIAS

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

64/ 100
Veridion Score
BUY BIAS · MEDIUM confidence
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: MEDIUM · 5/6 factors with data · Fri Aug 21 · last completed session · Pre-market · regular session opens 9:30 ET
Share on X →
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is ENVB moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading ENVB catalysts
About Enveric Biosciences Inc
PHARMACEUTICAL PREPARATIONS
Listed since
1995
Employees
6
Country
US

Enveric Biosciences Inc is a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, addiction, and other psychiatric disorders. The company's program, EB-003, is a first-in-class approach to the treatment of difficult-to-address mental health disorders designed to promote neuroplasticity without inducing hallucinations in the patient. The company is also developing EB-002, formerly EB-373, a next-generation synthetic prodrug of the active metabolite, psilocin, which is being studied as a treatment for psychiatric disorders.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$1.43
Last session
Day high
$1.43
Last session
Day low
$1.43
Last session
Previous close
$1.43
52W high
$17.40
-91.78% from high
52W low
$1.27
1% of range
Market cap
$6.4M
EPS
$-13.6200
Beta
0.23
Shares out
4.5M
Avg volume
139.9K
VWAP
$1.43
Last session
Price history computed in-house
1W
-3.38%
1M
+10.85%
3M
-35.87%
1Y
-90.23%
YTD
-60.61%
SMA 50 $1.42 · above
SMA 200 $2.97 · below
52W position 1%

ENVB overview

Veridion Score
64
Registered · 2026-08-21
5 of 6 factors measured
Latest receipt rows
0
No recent disclosure on file.
13F holders
None on file

Related filings and maps

Relationship mapTrace receipt-backed holders and filings around ENVB.Congress trackerSearch the public STOCK Act disclosure ledger.MethodologyReview score inputs, coverage rules, and limitations.
Loading financial statements
Loading ENVB Form 4 filings
Public disclosures

Congress activity in ENVB

Congress trackerOpen ticker disclosure ledger →

No receipt-qualified Congressional disclosure is present for ENVB in the cached public ledger.

Federal contracts

ENVB contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for ENVB in this window.
Lobbying spend

ENVB lobbying filings, year to date.

Registered lobbying filings matched to Enveric Biosciences Inc.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for ENVB in this window.
Loading news for ENVB
Analyst ratings
Sovereign unlock shows live analyst consensus for ENVB.
Options
Sovereign unlock shows live options positioning for ENVB.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.